Machlus KR, Thon JN, Italiano JE (April 2014). "Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation". British Journal of Haematology. 165 (2): 227–236. doi:10.1111/bjh.12758. PMID24499183. S2CID42595581.
Gaertner F, Massberg S (December 2016). "Blood coagulation in immunothrombosis-At the frontline of intravascular immunity". Seminars in Immunology. 28 (6): 561–9. doi:10.1016/j.smim.2016.10.010. PMID27866916.
Hampton T (April 2018). "Platelets' Role in Adaptive Immunity May Contribute to Sepsis and Shock". JAMA. 319 (13): 1311–2. doi:10.1001/jama.2017.12859. PMID29614158.
Cecerska-Heryć E, Goszka M, Dołęgowska B (2022). "Applications of the regenerative capacity of platelets in modern medicine". Cytokine & Growth Factor Reviews. 64: 84–94. doi:10.1016/j.cytogfr.2021.11.003. PMID34924312.
Furie B, Furie BC (August 2008). "Mechanisms of thrombus formation". The New England Journal of Medicine. 359 (9): 938–949. doi:10.1056/NEJMra0801082. PMID18753650.
Harker LA, Roskos LK, Marzec UM, Carter RA, Cherry JK, Sundell B, Cheung EN, Terry D, Sheridan W (April 2000). "Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers". Blood. 95 (8): 2514–22. doi:10.1182/blood.V95.8.2514. PMID10753829.
Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE (2012). "Endogenous inhibitory mechanisms and the regulation of platelet function". Platelets and Megakaryocytes. Methods in Molecular Biology. Vol. 788. pp. 341–366. doi:10.1007/978-1-61779-307-3_23. ISBN978-1-61779-306-6. PMID22130718.
Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R (April 2005). "Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection". Seminars in Thrombosis and Hemostasis. 31 (2): 234–246. doi:10.1055/s-2005-869528. PMID15852226. S2CID41764516.
Ahmad SS, Rawala-Sheikh R, Walsh PN (1992). "Components and assembly of the factor X activating complex". Seminars in Thrombosis and Hemostasis. 18 (3): 311–323. doi:10.1055/s-2007-1002570. PMID1455249. S2CID28765989.
O'Halloran AM, Curtin R, O'Connor F, Dooley M, Fitzgerald A, O'Brien JK, Fitzgerald DJ, Shields DC (February 2006). "The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets". British Journal of Haematology. 132 (4): 494–502. doi:10.1111/j.1365-2141.2005.05897.x. PMID16412022. S2CID41983626.
Gaertner F, Ahmad Z, Rosenberger G, Fan S, Nicolai L, Busch B, Yavuz G, Luckner M, Ishikawa-Ankerhold H, Hennel R, Benechet A, Lorenz M, Chandraratne S, Schubert I, Helmer S, Striednig B, Stark K, Janko M, Böttcher RT, Verschoor A, Leon C, Gachet C, Gudermann T, Mederos Y, Schnitzler M, Pincus Z, Iannacone M, Haas R, Wanner G, Lauber K, Sixt M, Massberg S (November 2017). "Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria". Cell. 171 (6): 1368–82. doi:10.1016/j.cell.2017.11.001. PMID29195076.
Murakawa M, Okamura T, Tsutsumi K, Tanoguchi S, Kamura T, Shibuya T, Harada M, Niho Y (1992). "Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment". Acta Haematologica. 87 (1–2): 83–87. doi:10.1159/000204725. PMID1585777.
van Genderen PJ, Leenknegt H, Michiels JJ, Budde U (September 1996). "Acquired von Willebrand disease in myeloproliferative disorders". Leukemia & Lymphoma. 22 (Suppl 1): 79–82. doi:10.3109/10428199609074364. PMID8951776.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–885. doi:10.1111/j.1537-2995.2004.03355.x. PMID15157255. S2CID24109912.
Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G (June 2005). "Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates". Transfusion. 45 (6): 911–9. doi:10.1111/j.1537-2995.2005.04350.x. PMID15934989. S2CID23169569.
Beale LS (1864). "On the Germinal Matter of the Blood, with Remarks upon the Formation of Fibrin". Transactions of the Microscopical Society & Journal. 12: 47–63. doi:10.1111/j.1365-2818.1864.tb01625.x.
Machlus KR, Thon JN, Italiano JE (April 2014). "Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation". British Journal of Haematology. 165 (2): 227–236. doi:10.1111/bjh.12758. PMID24499183. S2CID42595581.
Gaertner F, Massberg S (December 2016). "Blood coagulation in immunothrombosis-At the frontline of intravascular immunity". Seminars in Immunology. 28 (6): 561–9. doi:10.1016/j.smim.2016.10.010. PMID27866916.
Hampton T (April 2018). "Platelets' Role in Adaptive Immunity May Contribute to Sepsis and Shock". JAMA. 319 (13): 1311–2. doi:10.1001/jama.2017.12859. PMID29614158.
Cecerska-Heryć E, Goszka M, Dołęgowska B (2022). "Applications of the regenerative capacity of platelets in modern medicine". Cytokine & Growth Factor Reviews. 64: 84–94. doi:10.1016/j.cytogfr.2021.11.003. PMID34924312.
Furie B, Furie BC (August 2008). "Mechanisms of thrombus formation". The New England Journal of Medicine. 359 (9): 938–949. doi:10.1056/NEJMra0801082. PMID18753650.
Jain NC (June 1975). "A scanning electron microscopic study of platelets of certain animal species". Thrombosis et Diathesis Haemorrhagica. 33 (3): 501–7. PMID1154309.
Harker LA, Roskos LK, Marzec UM, Carter RA, Cherry JK, Sundell B, Cheung EN, Terry D, Sheridan W (April 2000). "Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers". Blood. 95 (8): 2514–22. doi:10.1182/blood.V95.8.2514. PMID10753829.
Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE (2012). "Endogenous inhibitory mechanisms and the regulation of platelet function". Platelets and Megakaryocytes. Methods in Molecular Biology. Vol. 788. pp. 341–366. doi:10.1007/978-1-61779-307-3_23. ISBN978-1-61779-306-6. PMID22130718.
Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R (April 2005). "Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection". Seminars in Thrombosis and Hemostasis. 31 (2): 234–246. doi:10.1055/s-2005-869528. PMID15852226. S2CID41764516.
Ahmad SS, Rawala-Sheikh R, Walsh PN (1992). "Components and assembly of the factor X activating complex". Seminars in Thrombosis and Hemostasis. 18 (3): 311–323. doi:10.1055/s-2007-1002570. PMID1455249. S2CID28765989.
O'Halloran AM, Curtin R, O'Connor F, Dooley M, Fitzgerald A, O'Brien JK, Fitzgerald DJ, Shields DC (February 2006). "The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets". British Journal of Haematology. 132 (4): 494–502. doi:10.1111/j.1365-2141.2005.05897.x. PMID16412022. S2CID41983626.
Gaertner F, Ahmad Z, Rosenberger G, Fan S, Nicolai L, Busch B, Yavuz G, Luckner M, Ishikawa-Ankerhold H, Hennel R, Benechet A, Lorenz M, Chandraratne S, Schubert I, Helmer S, Striednig B, Stark K, Janko M, Böttcher RT, Verschoor A, Leon C, Gachet C, Gudermann T, Mederos Y, Schnitzler M, Pincus Z, Iannacone M, Haas R, Wanner G, Lauber K, Sixt M, Massberg S (November 2017). "Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria". Cell. 171 (6): 1368–82. doi:10.1016/j.cell.2017.11.001. PMID29195076.
Murakawa M, Okamura T, Tsutsumi K, Tanoguchi S, Kamura T, Shibuya T, Harada M, Niho Y (1992). "Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment". Acta Haematologica. 87 (1–2): 83–87. doi:10.1159/000204725. PMID1585777.
van Genderen PJ, Leenknegt H, Michiels JJ, Budde U (September 1996). "Acquired von Willebrand disease in myeloproliferative disorders". Leukemia & Lymphoma. 22 (Suppl 1): 79–82. doi:10.3109/10428199609074364. PMID8951776.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–885. doi:10.1111/j.1537-2995.2004.03355.x. PMID15157255. S2CID24109912.
Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G (June 2005). "Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates". Transfusion. 45 (6): 911–9. doi:10.1111/j.1537-2995.2005.04350.x. PMID15934989. S2CID23169569.
Machlus KR, Thon JN, Italiano JE (April 2014). "Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation". British Journal of Haematology. 165 (2): 227–236. doi:10.1111/bjh.12758. PMID24499183. S2CID42595581.
Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R (April 2005). "Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection". Seminars in Thrombosis and Hemostasis. 31 (2): 234–246. doi:10.1055/s-2005-869528. PMID15852226. S2CID41764516.
Ahmad SS, Rawala-Sheikh R, Walsh PN (1992). "Components and assembly of the factor X activating complex". Seminars in Thrombosis and Hemostasis. 18 (3): 311–323. doi:10.1055/s-2007-1002570. PMID1455249. S2CID28765989.
O'Halloran AM, Curtin R, O'Connor F, Dooley M, Fitzgerald A, O'Brien JK, Fitzgerald DJ, Shields DC (February 2006). "The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets". British Journal of Haematology. 132 (4): 494–502. doi:10.1111/j.1365-2141.2005.05897.x. PMID16412022. S2CID41983626.
Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–885. doi:10.1111/j.1537-2995.2004.03355.x. PMID15157255. S2CID24109912.
Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G (June 2005). "Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates". Transfusion. 45 (6): 911–9. doi:10.1111/j.1537-2995.2005.04350.x. PMID15934989. S2CID23169569.